US FDA launches AI tool to reduce time taken for scientific reviews
Bengaluru: The U.S. Food and Drug Administration said on Monday that it had launched a generative
AI tool
,
Elsa
, aimed at improving efficiency across its operations, including
scientific reviews
.
"Today's rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers," said FDA Commissioner Marty Makary.
The agency said it is already using Elsa to expedite
clinical protocol reviews
, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets.
Once the FDA receives an application for a potential
drug approval
, it has six to 10 months to make a decision.
Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts.
"Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff," the FDA said.
In May, the regulator said it would fully integrate AI by June 30, following an experimental run.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
16 minutes ago
- Time of India
Alphabet to keep hiring engineers while AI advances
Alphabet Inc.'s Sundar Pichai said his company will keep expanding its engineering ranks at least into 2026, stressing human talent remains key even as Google 's parent ramps up AI investments. Speaking at the Bloomberg Tech conference in San Francisco, Pichai said he will continue to invest in engineering in the near future. US tech leaders like Microsoft Corp. have trimmed more staff this year, reflecting in part the enormous investments needed to ensure leadership in AI. The firings have stoked fears about the technology replacing certain job functions. Google itself has conducted rounds of layoffs in recent years to free up resources. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo 'I expect we will grow from our current engineering base even into next year, because it allows us to do more with the opportunity space,' Pichai said in conversation with Bloomberg's Emily Chang. 'I just view this as making engineers dramatically more productive, getting a lot of the mundane aspects out of what they do.' Still, Pichai presented a vision of AI that was at once optimistic about the technology's possibilities and sober-minded about some of its present limitations. While AI excels in areas like coding, the models continue to make basic mistakes, Pichai said. Live Events 'So are we currently on an absolute path to AGI? I don't think anyone can say for sure,' Pichai said. He was referring to artificial general intelligence: the dream of building AI that can perform on par with humans. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories As Google incorporates more AI into its search engine, publishers have sounded the alarm about how the company's AI-generated answers deprive them of traffic. Pichai stressed that the company remains committed to sending traffic to the web. 'Compared to most companies in the world, we take care to design an experience which is going to showcase links,' Pichai said. 'We took a long time testing AI Overviews and prioritized approaches which resulted in high quality traffic out. I'm confident that many years from now that's how Google will work.' Pichai has led Google since 2015, when he took the reins from Google co-founder Larry Page pledging to focus even more on AI. Asked about what qualities the public can expect to see in the company's next CEO, Pichai quipped: 'Whoever is running it will have an extraordinary AI companion.' At the same conference on Wednesday, Meta Platforms Inc. Chief Technology Officer Andrew Bosworth said that there's been a cultural shift in the Silicon Valley and it is now more palatable for the tech industry to support the US military's efforts. The company announced a partnership with defense contractor Anduril Industries Inc. last week to develop products for the US military, including an artificial intelligence-powered helmet with virtual and augmented reality features. Anduril's co-founder Trae Stephens and other industry leaders such as Perplexity AI Inc. Chief Executive Officer Aravind Srinivas will join the Bloomberg Tech summit on Thursday.
New Indian Express
27 minutes ago
- New Indian Express
IIT-D, AIIMS join forces to usher AI in healthcare
NEW DELHI: In a landmark collaboration that aims to reshape the future of medicine in India, IIT Delhi and AIIMS, Delhi have announced the creation of a Center of Excellence for Artificial Intelligence in Healthcare (AI-CoE). This initiative, backed by a substantial Rs 330 crore grant from the Ministry of Education's 'Make AI in India, Make AI Work for India' programme, aims to harness cutting-edge AI technology to tackle some of the nation's most pressing health challenges. The formal agreement was signed at IIT Delhi by Prof M Srinivas, Director of AIIMS Delhi, and Prof Rangan Banerjee, Director of IIT Delhi. The new center will serve as a hub for developing indigenous AI solutions, supporting national health programmes, and making advanced healthcare accessible to even the most remote communities. Prof Srinivas of AIIMS described the partnership as a 'far-reaching collaborative research' effort with the potential to transform healthcare delivery across India. Prof Banerjee echoed this optimism, emphasising the center's role in making AI-powered healthcare both affordable and impactful for millions. The AI-CoE will focus on upskilling healthcare providers, improving public health systems, and pioneering new models of collaboration between technology and medicine.
Hans India
39 minutes ago
- Hans India
AIIMS Delhi, IIT Delhi to establish Centre of Excellence for AI in healthcare
New Delhi: The All-India Institute of Medical Sciences (AIIMS) on Wednesday announced signing a partnership agreement with the Indian Institute of Technology (IIT) Delhi to establish a Center of Excellence for artificial intelligence in healthcare (AI-CoE). The AI-CoE will focus on developing AI-based solutions for supporting key national health programmes in the country. 'This MoU marks the beginning of far-reaching collaborative research that has the potential to change the face of healthcare in the country,' said Prof. M. Srinivas, Director, of AIIMS Delhi. 'A partnership between AIIMS and IIT Delhi has the potential to transform AI for affordable healthcare. We are delighted to be shaping this national centre of excellence and hope that our output will impact the lives of Indians,' added Prof. Rangan Banerjee, Director, of IIT Delhi. The Memorandum of Understanding (MoU) was signed by Prof Srinivas, and Prof. Banerjee at a ceremony held at IIT Delhi. Last year, the two institutes were awarded a grant of Rs 330 crore by the Ministry of Education under the initiative 'Make AI in India, Make AI Work for India,' following a rigorous and highly competitive selection process. The proposed Centre of Excellence will be the executing vehicle for the grant. The project aims to keep patients at the centre of and to build mechanisms that would benefit every citizen of the country. The CoE will serve as a key research and resource center at the national and international level and aims to revolutionise the national public health system using indigenously developed AI systems and solutions, said the experts. 'We aim to develop cutting-edge AI solutions to upscale health services, upskill our healthcare providers, and improve the accessibility of quality healthcare to remote and marginalised sections of our population,' said Prof. Chetan Arora, Chief Project Manager, who will lead the AI-CoE from IIT Delhi. IIT Delhi and AIIMS Delhi have a history of strong research collaboration, including the Centre for Advanced Research and Excellence in Disability & Assistive Technology (CARE-DAT) which is working to develop assistive technologies for persons with disabilities.
